The evidence shows that DJ-1 may be involved in various mechanisms in cancer progression, including the inhibition of cellular apoptosis, redox sensing, acting as a marker for chemotherapy resistance, suppression of ferroptosis, regulating histone glycation, and inhibition of autophagy [9–13]. The gene discussed is PARK7; the disease is cancer.